type here...

CATEGORIES

Medication

LATEST

1234Page 3 of 4

TRENDING

EDITORS CHOICE

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

James Coyne -
Research concerning the role of psychedelics in mental health treatment and its superb publicity campaign depends on millions of dollars raised by venture capitalists.

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

James Coyne -
All claims about treatments affecting human health and well-being should be subject to robust review. That review requires someone to facilitate criticism, locate qualified critics, and bring them into the discussion.

First Drug Synthesized by AI Goes into Clinical Trials

Dr Sohail Merchant -
If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.

Exponential Innovation: Disrupting The Disruptor

John Nosta -
Today's world of disruptive change is defined by two terms: innovation and speed.  The big idea is important, but equally so is the path that innovation...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories